Allen Investment Management’s Gilead Sciences GILD Stock Holding History

Allen Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$610K	Hold	4,829	–	–	0.01%	178
2026 Q1	$673K	Hold	4,829	–	–	0.01%	174
2025 Q4	$593K	Buy	+4,829	New	+$587K	0.01%	178
2016 Q3	–	Sell	-4,359	Closed	-$364K	–	211
2016 Q2	$364K	Hold	4,359	–	–	0.03%	165
2016 Q1	$400K	Hold	4,359	–	–	0.03%	147
2015 Q4	$441K	Hold	4,359	–	–	0.04%	137
2015 Q3	$428K	Buy	4,359 +1,095	+34%	+$122K	0.04%	146
2015 Q2	$382K	Hold	3,264	–	–	0.04%	159
2015 Q1	$320K	Hold	3,264	–	–	0.02%	186
2014 Q4	$308K	Buy	+3,264	New	+$338K	0.02%	188

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Allen Investment Management's GILD Position: Q2 2026 in Review

Allen Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,829 shares worth $610K. The position accounts for 0.01% of the portfolio, ranked #178.

Allen Investment Management first reported a position in GILD in Q4 2014 and has held it in 10 quarters since. The position peaked at $673K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Allen Investment Management held 4,829 shares of Gilead Sciences worth $610K as of Q2 2026.
Allen Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Allen Investment Management's portfolio in Q2 2026, its #178 holding.
Allen Investment Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 10 quarters since.
Allen Investment Management's Gilead Sciences position peaked at $673K in Q1 2026.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Allen Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.